As per a recent market analysis by Future Market Insights (FMI), the pharmacovigilance market is poised to reach a valuation of US$ 6.28 million in 2022. Demand is projected to increase at a 13.1 % CAGR during the forecast period.
| Attributes | Details |
| Pharmacovigilance Market CAGR (2022-2032) | 13.1% |
| Pharmacovigilance Market Size (2022) | US$ 6.28 billion |
| Pharmacovigilance Market Size (2032) | US$ 24.32 billion |
There is a rising demand for safer medications as a result of growing public knowledge of the negative effects of OTC medications. Due to the monitoring of easily available pharmaceuticals for potential adverse drug reactions, it is projected that this feature would increase the demand for pharmacovigilance.
Pharmacovigilance businesses can clearly benefit from outsourcing in terms of time constraints and the facilities that an outsourced service may provide. Outsourcing additionally enables companies to tailor services to their needs, hastening the evaluation process.
However, due to problems including the high risk associated with data security, the absence of worldwide regulatory harmonization, and the lack of data standardization for adverse event gathering, the pharmacovigilance market may experience a slowdown during the projected period.
Many clinical studies are currently predicted to be conducted to assess the efficacy of various pharmaceutical candidates, providing new growth prospects for UK-based pharmacovigilance solution providers.
Due to the market competitiveness for the release of innovative substances, there is a large demand for improved manufacturing processes, pharmacovigilance, clinical data management, streamlined R & D, and medical writing.
Get a Sample Copy of Report@
https://www.futuremarketinsights.com/reports/sample/rep-gb-1107
Key Takeaways
- The pharmacovigilance market is likely to have a CAGR of 13.1% during the forecast period.
- According to the phases of drug development, the phase IV stage generates around 75% of the revenue in 2021 for the pharmacovigilance market.
- North America holds the highest share of 30.0% in the global pharmacovigilance market.
- Based on the type of method, spontaneous reporting accounted for the biggest share of almost 30% in 2021.
- During the forecast period, the pharmacovigilance market in Asia Pacific is anticipated to expand at a CAGR of 12.1%.
- Based on service type, contract outsourcing dominates the pharmacovigilance market, with a share of 55%.
- The value of the pharmacovigilance market is expected to be US$ 24.32 billion by 2032.
Competitive Landscape:
While focusing on technology advancement, market participants are constantly creating safety services to promote the acceptance of pharmacovigilance services. Automation, artificial intelligence, and analytics have improved the efficiency of companies that provide pharmacovigilance services. Collaborations with leading pharmaceutical corporations are a crucial tactic for some pharmacovigilance market participants.
For any Queries Linked with the Report, Ask an Analyst@
https://www.futuremarketinsights.com/ask-question/rep-gb-1107
Key segments
By Phase of Drug Development:
- Preclinical Studies
- Phase I
- Phase II
- Phase III
- Phase IV
By Type of Methods:
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Spontaneous Reporting
- Cohort Event Monitoring
- EHR Mining
By Service Type Provider:
- In-house Pharmacovigilance
- Contract Outsourcing
By Geography:
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
Read Related Reports:
https://vocal.media/stories/liquid-biopsy-market-2022-scope-of-current-and-future-industry-2031
https://degentevakana.com/blogs/view/118096
https://degentevakana.com/blogs/view/118100
https://vocal.media/stories/dental-imaging-equipment-market-2022-scope-of-current-and-future-industry-2030
About FMI
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
Report: https://www.futuremarketinsights.com/reports/pharmacovigilance-market
For Sales Enquiries: sales@futuremarketinsights.com
Browse latest Market Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs